Cutting-Edge Research for Global Health
At Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), microbiologists, virologists, and other scientists focus on the increasing incidence of emerging infectious diseases. Many of these pathogens pose the threat of causing large scale epidemics or global pandemics. The goal of the NEIDL is to predict their appearance, detect, study, and respond to them in a timely manner. Because of the NEIDL’s extraordinary biocontainment capabilities, researchers have been able to work safely with a variety of live pathogens including COVID-19, HIV/AIDS, Ebola/Marburg, Zika, Yellow Fever, among others. Understanding basic molecular aspects of a pathogen, the interplay of the pathogen with its host, transmission dynamics, and clinical manifestations are all essential for the development of better diagnostics and safe, effective therapeutics and vaccines for us to treat, or even better, be able to prevent these diseases.
In the News
-
BU’s Leading Home for Infectious Diseases Research to Get Major Upgrade with NIH Grant
One of just two National Biocontainment Laboratories in the United States, the NEIDL has just been given a $7.5 million grant from the National Institutes of Health to modernize its facilities and help broaden its impact.
-
NEIDL Researcher Quoted In Washington Post on H5N1
The recent bird flu outbreak is being regarded as the largest animal disease outbreak on record, raising concerns about its potential to spark a pandemic.
-
NEIDL Researcher Florian Douam, PhD, Receives Smith Family Foundation’s Odyssey Award
Two junior faculty members have been awarded Smith Family Foundation’s...